Warfarin, rivaroxaban similarly safe, effective

September 12, 2017

(HealthDay)—For cases of mild atrial fibrillation (AF)-related acute ischemic stroke, rivaroxaban and warfarin are similarly safe and effective at preventing recurrent stroke, according to a study published online Sept. 11 in JAMA Neurology.

Keun-Sik Hong, M.D., from Inje University in Goyang, South Korea, and colleagues compared rivaroxaban or warfarin sodium for prevention of early in patients with AF-related . Patients were randomized (1:1) to receive rivaroxaban (10 mg/day for five days followed by 15 or 20 mg/day; 95 participants) or warfarin with a target international normalized ratio of 2.0 to 3.0 (88 participants), for four weeks.

The researchers found that the two groups showed no differences in the primary composite end point (P = 0.49) or its individual components: new ischemic lesion (relative risk [RR], 0.83; 95 percent confidence interval, 0.54 to 1.26; P = 0.38) or new intracranial hemorrhage (RR, 1.10; 95 percent confidence interval, 0.70 to 1.71; P = 0.68). Each group had one clinical ischemic stroke. All new intracranial hemorrhages were asymptomatic hemorrhagic transformations. Rivaroxaban was associated with reduced hospitalization length compared with warfarin (median, 4.0 days versus 6.0 days; P < 0.001).

"In mild AF-related acute ischemic , rivaroxaban and had comparable safety and efficacy," the authors write.

Several authors disclosed financial ties to pharmaceutical companies, including Bayer, which partially funded the study.

Explore further: Lower inpatient costs for dabigatran, rivaroxaban in A-fib

More information: Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Related Stories

Lower inpatient costs for dabigatran, rivaroxaban in A-fib

January 17, 2017
(HealthDay)—For patients with newly diagnosed atrial fibrillation (AF), inpatient costs are lower with dabigatran and rivaroxaban than with warfarin, according to a letter published online in the Jan. 24 issue of the Journal ...

Rivaroxaban OK for stroke prevention in cancer patients

July 13, 2017
(HealthDay)—The safety and efficacy of rivaroxaban treatment for nonvalvular atrial fibrillation (AF) in patients with active cancer is similar to the general population, according to a study published in the July 15 issue ...

Use of novel oral anticoagulants increasing in A-fib

June 15, 2015
(HealthDay)—For patients with atrial fibrillation hospitalized with stroke or transient ischemic attack, use of novel oral anticoagulants (NOACs) has increased over time, according to a study published online June 9 in ...

Rivaroxaban has less risk of brain bleeding in patients at high risk for stroke

February 2, 2012
For patients with a type of irregular heart beat called atrial fibrillation (AF), a new anti-clotting drug might be better at preventing clot-related strokes while minimizing the risk of causing a bleeding stroke. The research ...

Anticoagulants used for arrhythmia can have different thrombus formation rates

August 24, 2017
Anticoagulants are recommended for atrial fibrillation due to the high risk of stroke. However, bleeding complications can occur as a side effect. Researchers in Japan examined several types of anticoagulants and found that ...

Intra-arterial treatment effective with extracranial carotid disease

June 1, 2017
(HealthDay)—Acute intra-arterial treatment (IAT) seems to be as effective for patients with acute ischemic stroke caused by intracranial proximal occlusion with, versus those without, extracranial carotid disease (ECD), ...

Recommended for you

Researchers discover novel mode of neurotransmitter-based communication

May 21, 2018
Researchers at the University of California, Irvine School of Medicine have discovered the first example of a novel mode of neurotransmitter-based communication. The discovery, published in Nature Communications, challenges ...

Mice regrow brain tissue after stroke with bioengineered gel

May 21, 2018
In a first-of-its-kind finding, a new stroke-healing gel helped regrow neurons and blood vessels in mice with stroke-damaged brains, UCLA researchers report in the May 21 issue of Nature Materials.

Reading the minds of pilots on the fly

May 21, 2018
After a plane engine blew apart at 32,000 feet in the air last month, the pilot flying Southwest Flight 1380 safely brought the Boeing 737 to an emergency landing in Philadelphia. Captain Tammie Jo Shults was heralded a hero, ...

Vascular risk interacts with amyloid levels to increase age-related cognitive decline

May 21, 2018
Risk factors for heart disease and stroke appear to hasten the risk of cognitive decline in normal older individuals with evidence of very early Alzheimer's-disease-associated changes in the brain. Vascular risk factors increase ...

Casting light on better bowels

May 21, 2018
A novel light therapy is being investigated as an alternative to prescription drugs to relieve chronic constipation and other intestinal disorders which affect millions of patients around the world.

How social isolation transforms the brain

May 17, 2018
Chronic social isolation has debilitating effects on mental health in mammals—for example, it is often associated with depression and post-traumatic stress disorder in humans. Now, a team of Caltech researchers has discovered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.